While annual HIV surveillance reports released by the CDC in May showed that the number of estimated new HIV infections per ...

In the complex landscape of chronic health conditions, living with HIV while recovering from a stroke presents a unique set ...

The second of two pivotal studies of a six-monthly HIV prevention injection containing the antiretroviral drug lenacapavir ...

The measure waives the need for a primary care physician’s prescription for HIV medications like PrEP and Doxy PEP.

Lenacapavir is a long-acting injectable drug that has proven 100 per cent successful in clinical tests and subsequent human ...

Following the passing of popular Benga songstress Princess Jully this past weekend, fans and Kenyans have come out to honour ...

Babies born to mothers with HIV should receive HIV drugs within six hours after birth to prevent mother-to-child transmission ...

In order to counter such stigma and discrimination, women living with HIV and Hepatitis B came together at The Voice of ...

In June, we heard what could be this year's biggest HIV breakthrough: a twice-yearly injection can prevent HIV infection. Findings from a second large study of the jab has now confirmed that it works.

The sense of urgency around HIV has waned as it competes with other global crises for attention and funding, leading to a ...

Within two to four weeks after HIV infection, many, but not all, people develop flu-like symptoms, including fever, swollen ...

This year clinical trial results for PURPOSE 1 and 2 showed the high prevention effectiveness of the 6-monthly long-acting injectable drug, lenacapavir for cisgender adolescent girls and women, ...